Related Experiment Videos
The cytokine storm in multiple sclerosis
1Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Abstract:
MS is associated with a cytokine storm characterized by the parallel upregulation of proinflammatory (IFN-gamma, TNF-alpha, and beta, and IL-12) and immune response-down-regulating (TGF-beta, IL-10) cytokines. Also IL-6 and the cytolytic molecule perforin are upregulated. Even when evaluated in individual MS patients over the disease course, no Th1/Th2 dichotomy is obvious but, instead, upregulation of Th1 + Th2 + Th3 cytokines simultaneously, probably reflecting the complex pathology of MS in lesion size, time and distribution in the individual patient. Few correlations have been observed between cytokines and clinical MS variables, though upregulation of TGF-beta seems to correlate with benign course and minor disability. Both pro- and antiinflammatory cytokines are also produced by microglia and astrocytes, constituting a CNS-cytokine network that interacts with the cytokine network of the immune system. This complexity is to be kept in mind when searching for cytokine abnormalities in MS.
Insights
Multiple sclerosis (MS) involves a complex cytokine storm with simultaneous upregulation of pro- and anti-inflammatory cytokines, challenging simple Th1/Th2 classifications. This intricate immune response within the central nervous system (CNS) impacts MS pathology.
Area of Science:
- Neuroimmunology
- Cytokine Biology
- Multiple Sclerosis Pathogenesis
Background:
- Multiple sclerosis (MS) is characterized by a complex cytokine storm.
- Both pro-inflammatory (e.g., IFN-gamma, TNF-alpha, IL-12) and anti-inflammatory (e.g., TGF-beta, IL-10) cytokines are upregulated.
- Interleukin-6 (IL-6) and perforin are also elevated in MS patients.
Purpose of the Study:
- To investigate the complex cytokine profiles in multiple sclerosis.
- To understand the interplay between central nervous system (CNS) and systemic immune responses in MS.
- To explore potential correlations between cytokine levels and clinical MS variables.
Main Methods:
- Analysis of cytokine expression patterns in individual MS patients over time.
- Evaluation of cytokine production by CNS-resident cells like microglia and astrocytes.
- Correlation analysis between cytokine levels and clinical disease parameters.
Main Results:
- A simultaneous upregulation of Th1, Th2, and Th3 cytokines was observed, refuting a simple Th1/Th2 dichotomy.
- Cytokine profiles varied within individual patients throughout the disease course.
- Upregulation of transforming growth factor-beta (TGF-beta) showed a potential correlation with a benign MS course and reduced disability.
Conclusions:
- The cytokine dysregulation in MS is complex, involving simultaneous activation of multiple immune pathways.
- The CNS cytokine network, involving glial cells, interacts with the systemic immune system.
- Understanding this complexity is crucial for identifying therapeutic targets and interpreting cytokine abnormalities in MS.